# Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.

> **NCT05397769** · PHASE2 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 36 (estimated)

## Conditions studied

- Locally Advanced Nasopharyngeal Carcinoma
- Envafolimab
- Induction Chemotherapy
- PD-L1

## Interventions

- **DRUG:** Envafolimab Plus Chemoradiotherapy

## Key facts

- **NCT ID:** NCT05397769
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-08
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2022-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05397769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05397769, "Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05397769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*